QMatter, Inc. funding
QMatter, Inc., a biotechnology company based in London, United Kingdom (founded 2024), filed a Form D with the SEC on April 9, 2026 and reported $1.2M raised.
Amount raised$1.2M
Offering size$1.2M
Filed with the SECApril 9, 2026
First saleMarch 26, 2026
IndustryBiotechnology
SecuritiesEquity
LocationLondon, United Kingdom
Founded2024
Entity typeCorporation
Investors so far4
Minimum investment$1
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 9
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology